West Pharmaceutical Services (WST)

Long-Term Debt

$291.20M

Quarterly · Period ending: · USD

WST logo

WST Long-Term Debt

Latest reported$291.20M
WST Quarterly Long-Term Debt ($26.00M → $291.20M)
High-resolution chart · PNG

WST long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

West Pharmaceutical Services Long-Term Debt — Quarterly (USD)
Period endingLong-Term Debt (USD)
195,100,000
195,200,000
195,800,000
192,000,000
172,600,000
130,700,000
141,500,000
155,400,000
160,300,000
139,600,000
105,000,000
94,900,000
95,200,000
84,900,000
87,400,000
88,000,000
89,100,000
90,600,000
95,500,000
95,000,000
106,900,000
97,900,000
104,500,000
105,500,000
82,100,000
72,000,000
35,900,000
23,200,000
26,000,000
25,200,000
24,600,000
30,600,000
32,800,000
30,200,000
31,500,000
42,100,000
43,700,000
47,300,000
49,100,000
52,700,000
53,500,000
65,100,000
66,200,000
66,600,000
60,600,000
56,200,000
52,100,000
48,800,000
51,300,000
29,700,000
26,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.